Skip to main content
Portfolio
Active companies
Exited companies
Emerging Managers
Founders
Company Founders
Emerging
Manager
Partners
About Inovia
Team
Advisors
ESG
Gen AI
Inovia Conversations
Careers
Open the accessibility toolbar.
Color scheme
High contrast
Font size
Font size
Normal
Font size
Bigger
Font size
Biggest
Animations
Disable animations
Close accessibility menu
Open search window
Close search window.
Open site navigation
Search for:
Open the accessibility toolbar.
Open site navigation
Investor Portal
Press Room
Portfolio
Active companies
Exited companies
Emerging Managers
Founders
Company Founders
Emerging
Manager
Partners
About Inovia
Team
Advisors
ESG
Gen AI
Inovia Conversations
Careers
Investor portal
Press Room
Press room company:
BenchSci
press-room
BenchSci: Building the Disease Biology Generative AI Platform for Pharma R&D
View press-room
press-room
Inovia Charts a Course for VC in the Generative AI Age
View press-room
press-room
Canada Helped Lay the Foundations for Today’s AI Boom. Can It Reap the Rewards?
View press-room
press-room
BenchSci, Inovia, Ada Among #CDNTech Orgs Pledging to Fight Workplace Hate in Wake of Israel-Hamas War
View press-room
press-room
Al Gore-led Fund Leads CAD$95M Investment in Toronto’s BenchSci, Which Uses AI to Hasten Drug Discovery
View press-room
press-room
AI Drug Discovery Startup BenchSci Scores $63 Million Series C Round Led by Inovia, TCV
View press-room